Table IV.
Results of univariate analysis of the clinical characteristics of the survival and non-survival groups.
| Variables | Survival group (%) | Non-survival group (%) | P-value |
|---|---|---|---|
| Age >70 years | 12.5 | 66.7 | 0.014 |
| Male gender | 55 | 100 | 0.128 |
| Eye involvement | 87.5 | 100 | 0.515 |
| Oral mucosa involvement | 97.5 | 100 | 0.782 |
| Genital involvement | 52.5 | 100 | 0.110 |
| Involvement of 3 mucosal areas | 42.5 | 100 | 0.054 |
| Renal involvement | 22.5 | 33.3 | 0.668 |
| Liver involvement | 50.0 | 33.3 | 0.578 |
| Duration prior to admission >72 h | 30.0 | 33.3 | 0.903 |
| Diabetes mellitus | 10 | 33.3 | 0.224 |
| Hypertension | 25 | 33.3 | 0.750 |
| Chronic kidney disease | 12.5 | 33.3 | 0.315 |
| HIV positive | 30.0 | 33.3 | 0.903 |
| Malignancy | 10 | 33.3 | 0.224 |
| Gout | 12.5 | 33.3 | 0.315 |
| Heart rate >100 bpm | 35 | 66.7 | 0.274 |
| BUN >20 mg/dl | 37.5 | 66.7 | 0.319 |
| Serum bicarbonate <20 mEq/l | 27.5 | 66.7 | 0.154 |
| WBC >10,000 | 15 | 0 | 0.470 |
| BSA involvement >20% | 22.5 | 100 | 0.004 |
| Steroid treatment | 65.1 | 0 | 0.014 |
| Antibiotics use | 30 | 100 | 0.014 |
| Fluid in 24 h >2,500 ml | 70 | 100 | 0.206 |
| Infection | 30 | 100 | 0.014 |
| SCORTEN >2 | 27.5 | 66.7 | 0.154 |
HIV, human immunodeficiency virus; BUN, blood urea nitrogen; WBC, white blood cell count; BSA, body surface area, SCORTEN, score of toxic epidermal necrolysis.